New BioAge Drug Prevents Death From COVID-19 in Old Mice by Reversing Immune Aging - SciTechDaily

A Phase 2 clinical trial is testing the new drug's ability to reduce mortality in older people hospitalized with COVID-19. By directly targeting immune aging, BGE-175 could effectively treat emerging COVID variants that evade vaccine-based immunity. The immun…

A Phase 2 clinical trial is testing the new drug’s ability to reduce mortality in older people hospitalized with COVID-19. By directly targeting immune aging, BGE-175 could effectively treat emerging… [+7086 chars]

full article...